Bigfoot Biomedical

Bigfoot Biomedical is a diabetes technology company focused on simplifying insulin therapy and improving glucose management for people living with insulin-dependent diabetes. Rather than relying on complex devices or manual dose calculations, Bigfoot delivers connected diabetes management solutions that combine continuous glucose monitoring data with smart insulin delivery tools to provide personalized, real-time insulin dosing guidance. Its Bigfoot Unity™ Diabetes Management System supports people using multiple daily injections by offering actionable insights, dose recommendations, and trend awareness that help reduce variability and support consistent glycemic control. Healthcare providers benefit from configurable clinical settings, shared data visibility, and tools that promote therapy adherence and informed decision-making. When evaluating Bigfoot Biomedical, consider device compatibility, dosing intelligence, ease of use for patients, and clinical evidence demonstrating improved outcomes and safety in real-world diabetes care environments.

Bigfoot Biomedical belongs to the Diabetes Management, Insulin Management, Glycemic Management, Glycemic Intelligence Platform category.

Bigfoot Biomedical is used in industries such as Health, Hospital & Health Care.

Bigfoot Biomedical is built for Small Business, Mid Size Business

Bigfoot Biomedical supports English

Bigfoot Biomedical supports Web-based, Windows devices.

No, Bigfoot Biomedical does not offer a free trial.

Bigfoot Biomedical was founded in 2014.

Bigfoot Biomedical has approximately 11-50 employees.

Bigfoot Biomedical is located in United States.

Bigfoot Biomedical was founded by Bigfoot Biomedical.